Position in ALNY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,372,116
-$728,684 QoQ
Shares Held
7,880
+15.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#305
of 764 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WINTON GROUP Ltd holds $97,029,578 across 91 Biotechnology names. ALNY ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
254,408 | $28,839,690 | |
| 2 | FTRE |
Fortrea Holdings Inc.
|
389,155 | $6,771,297 | |
| 3 | EXEL |
Exelixis, Inc.
|
99,834 | $5,431,967 | |
| 4 | TECH |
BIO-TECHNE Corp
|
67,227 | $4,749,587 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
60,348 | $4,723,437 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
90,546 | $3,532,199 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
7,880 | $2,372,116 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
106,852 | $1,992,789 |
All Filings in ALNY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,372,116 | 7,880 | Shares | Sole | 2026-08-07 | |
| 2025-09-30 | $3,100,800 | 6,800 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,152,075 | 3,533 | Shares | Sole | 2025-08-14 | |
| 2024-03-31 | $219,840 | 1,471 | Shares | Sole | 2024-05-14 | |
| 2023-03-31 | $686,096 | 3,425 | Shares | Sole | 2023-05-12 | |
| 2022-03-31 | $497,381 | 3,046 | Shares | Sole | 2022-05-11 | |
| 2021-09-30 | $549,625 | 2,911 | Shares | Sole | 2021-10-28 | |
| 2020-09-30 | $1,208,188 | 8,298 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $5,149,784 | 34,770 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $978,017 | 8,985 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||